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Abstract
 
The basic helix-loop-helix transcription factors encoded by the E2A gene function at the apex
of a transcriptional hierarchy involving E2A, early B cell factor (EBF), and Pax5, which is essen-
tial for B lymphopoiesis. In committed B lineage progenitors, E2A proteins have also been
shown to regulate many lineage-associated genes. Herein, we demonstrate that the block in B
lymphopoiesis imposed by the absence of E2A can be overcome by expression of EBF, but not
Pax5, indicating that EBF is the essential target of E2A required for development of B lineage
progenitors. Our data demonstrate that EBF, in synergy with low levels of alternative E2A-
related proteins (E proteins), is sufficient to promote expression of most B lineage genes. Re-
markably, however, we find that E2A proteins are required for interleukin 7–dependent prolif-
eration due, in part, to a role for E2A in optimal expression of N-
 
myc
 
. Therefore, high levels of
E protein activity are essential for the activation of EBF and N-
 
myc
 
, whereas lower levels of E
protein activity, in synergy with other B lineage transcription factors, are sufficient for expression
of most B lineage genes.
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Introduction
 
The development of B lymphocytes from multipotent he-
matopoietic progenitors depends on appropriate expression
of lineage-associated genes, rearrangement of IgH and light
chain gene segments, and responsiveness to stromal cell–
derived cytokines (1). B lineage specification and commit-
ment is orchestrated by multiple transcriptional regulatory
proteins that function in a complex network to control gene
expression (2, 3). The basic helix-loop-helix (bHLH) tran-
scription factors encoded by the E2A gene are absolutely
required for B lymphocyte development from the earliest
identifiable progenitors (4, 5). There are four E proteins
in mammals, E12 and E47, which are alternatively spliced
products of the E2A gene, HEB, and E2-2, all of which
bind the E-box motif (CANNTG; 6). These four proteins
share a high degree of sequence identity in the bHLH domain,
which is required for DNA binding and protein dimeriza-
tion, and in the two known activation domains. In B lym-
phocyte progenitors (BLPs), the major E-box binding pro-
tein is E47, consistent with the specific requirement for E2A
proteins in B lymphocyte development (7, 8).
Three independent strains of E2A-deficient mice have
been created and all have an identical phenotype: a com-
plete absence of B220
 
  
 
CD19
 
  
 
cells (Fraction B), Ig gene
rearrangements, and most B lineage–associated gene ex-
pression in the BM and fetal liver (FL; 4, 5, 9). Mice lack-
ing HEB or E2-2 do not have an overt B lymphocyte defect,
however, mice that are heterozygous for mutations in E2A
and HEB or E2-2 have a notable reduction in B lym-
phopoiesis compared with E2A-heterozygous mice (10). It
is currently not known whether the distinct E proteins are
functionally redundant, although this hypothesis is supported
by the observation that B lymphocytes develop in E2A-
deficient mice that express HEB from the E2A genomic
locus (11).
The E proteins were cloned based on their ability to
bind to sequences in the IgH and Ig
 
  
 
enhancers (12, 13). In
fact, E2A proteins are sufficient to induce the expression of
IgH and Ig
 
  
 
loci in many cell types (14–16). In addition,
they have been implicated in expression of the RAGs
(RAG-1 and RAG-2), terminal deoxynucleotide trans-
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ferase, and early B cell factor (EBF), a transcription factor
required for B lymphopoiesis at the same stage of develop-
ment as E2A (17, 18). E2A and EBF cooperatively regulate
the expression of the surrogate light chain proteins 
 
 
 
5 and
VpreB and the signal-transducing protein mb-1 (Ig-
 
 
 
; 19,
20). The transcription factor Pax5, which is essential for B
lineage commitment, but not B lineage specification, has
been proposed to be a target of EBF and possibly E2A (21).
These observations have led to the conclusion that a tran-
scriptional hierarchy exists in which E2A proteins induce
the expression of EBF followed by Pax5 and consequently
B lineage specification and commitment (2, 3).
In this study we have tested the hypothesis that EBF is
the essential target of E2A required for the development of
BLPs by expressing EBF in hematopoietic progenitors from
E2A-deficient mice. If EBF is the only essential target of
E2A at this stage of development, we would predict that
expression of EBF would be sufficient to promote B lin-
eage specification and commitment in the absence of E2A.
Alternatively, E2A may have many essential targets in BLPs
in which case EBF may fail to rescue, or only rescue some
aspects, of BLP development. Moreover, a partial rescue
could provide important insights into the functions of E2A
in B lymphopoiesis. Our experiments indicate that induc-
tion of EBF is the major function of E2A in promoting the
specification of BLPs. However, E2A proteins are also re-
quired to establish an appropriate cellular context for opti-
mal induction of N-
 
myc
 
 and responsiveness to the lym-
phopoietic cytokine IL-7. In addition, we find that distinct
thresholds of E protein activity are required for the induc-
tion of EBF and N-
 
myc
 
 as compared with other B lineage
genes. Taken together, our data demonstrate that E2A pro-
teins provide a central link between the induction of B lin-
eage–specific gene expression and expansion of BLPs.
 
Materials and Methods
 
Mice and Genotyping.
 
Mice were housed at the University of
Chicago Animal Resource Center. E47
 
 
 
/
 
  
 
mice have been de-
scribed previously (9). The E47 mutation was identified by PCR
using the primers E47bas forward 5
 
 
 
-CAGATGAGGTGCT-
GTCCCGGA-3
 
  
 
and E47bas reverse 5
 
 
 
-CAGGATCACCTG-
CACCGCCT-3
 
  
 
as described previously (9).
 
Isolation, Infection, and Culture of FL Progenitors.
 
FLs were har-
vested from E47
 
 
 
/
 
  
 
and E47
 
 
 
/
 
  
 
embryos between E12 and E13
after the mating of E47
 
 
 
/
 
  
 
male mice with E47
 
 
 
/
 
  
 
female mice.
Pooled FL populations were depleted of cells expressing Gr-1,
CD11b, and Ter119 (Lin
 
 
 
) by incubation with biotinylated anti-
bodies (BD Biosciences) followed by streptavidin magnetic beads.
They were then passed over a magnetic column (Miltenyi Bio-
tec). In the case of FL cells used for ex vivo examination of EBF
and Pax5, mRNA levels the Lin
 
  
 
cocktail also included CD19.
Depleted FL cells were spin infected for 2 h at 10
 
6 
 
cells/ml of vi-
ral supernatant containing the S003 (green fluorescent protein
[GFP]), S003EBF (EBF), or MigR1-Pax5 (Pax5) retrovirus as de-
scribed previously (22). The cells were then cultured on a sub-
confluent layer of irradiated S17 stromal cells (2,000 rads) in
OPTI-MEM supplemented with 10% FBS, 2 
 
  
 
10
 
 
 
5 
 
M 2-mer-
captoethanol, 1
 
  
 
penicillin/streptomycin/glutamine, a 1:100 di-
lution of IL-7 supernatant (provided by F. Melchers, University
of Basel, Basel, Switzerland), and a 1:500 dilution of c-
 
kit
 
 ligand
(KL; Genetics Institute). Retroviral supernatants were produced
from Pheonix cells as described previously (23).
Subsequent infection of E47
 
 
 
/
 
 
 
;GFP or E47
 
 
 
/
 
 
 
;EBF cells
with S003ERId3, S003ERId3m, pCS-ret (a derivative of S003 in
which GFP was replaced with the extracellular domain of human
CD25), or PCS-Id3 were performed as described above. FL pro-
genitors used for infection with the S003ERId3 or S003ERId3m
retroviruses were isolated from C57Bl/6 embryos at E13 and cul-
tured under the conditions described above for 15 d before infec-
tion. 36 h after infection, GFP
 
  
 
cells were isolated on a cell sorter
and cultured for an additional 20 h before the addition of 1 
 
 
 
M
17
 
 
 
-estradiol for 6 h. Limiting dilution assays were performed as
described previously (24, 25).
 
Construction of Retroviral Vectors.
 
S003EBF was created by li-
gation of rat EBF (provided by R. Reed, Johns Hopkins School of
Medicine, Baltimore, MD) into the S003 retroviral vector using
XhoI and NotI. S003ERId3 and S003ERId3m were cloned by
PCR amplification of Id3 or Id3m from TAT-Id3 or TAT-Id3m
using PCR primers 5
 
 
 
HA(EcoRI); 5
 
 
 
-GGAATTCACCATGT-
CCGGCTATCCATATGACGTCCCAGACTATGCTGGCT -
CCATGGCCGGTACC-3
 
  
 
and TATI-d3rev (22). The amplified
fragment was blunt end ligated into the EcoRV site of pBSK and
then isolated by digestion with EcoRI. The EcoRI fragment was
cloned into pBSKER digested with EcoRI, thereby ligating HA-
Id3 or HA-Id3m in-frame with the estrogen hormone binding do-
main. The ERId3 and ERId3m fragments were isolated from
pBSKERId3 and pBSKERId3m by digestion with XhoI and
NotI, and ligated to S003 digested with XhoI and NotI producing
S003ERId3 and S003ERId3m. pCS-Id3 was created by ligation of
Id3 digested with EcoRI into the EcoRI site of pCS-ret.
 
Flow Cytometry.
 
Cells were stained with anti–B220-cy5,
anti–CD19-PE, anti–BP-1-PE (BD Biosciences) as described
previously (26). Staining with anti–bromodeoxyuridine (BrdU)-
FITC (eBioscience) and propidium iodide (PI) for cell cycle anal-
ysis was performed as described by Kee et al. (22) after the addi-
tion of 1 
 
 
 
M BrdU to cells in culture for 20 min. The cells were
analyzed on a FACSCalibur™ (Becton Dickinson) using the
CELLQuest™ Pro software package.
 
Real Time RT-PCR Analysis.
 
Total RNA was isolated using
Trizol (Invitrogen) primed with oligo dT
 
18 
 
and was reverse tran-
scribed with M-MuLV reverse transcriptase (New England Bio-
labs, Inc.). Intron-spanning PCR primers were designed to avoid
amplification of genomic DNA, whereas product sizes were kept
to 
 
 
 
100 bp to maximize amplification efficiency. Each PCR re-
action was set up with first strand cDNA, HPLC-purified primers,
passive reference dye, and SYBR Green QPCR Master Mix
(Stratagene) according to the manufacturer’s instructions. Real
time PCR was performed in replicates of three to five on an MX-
4000 instrument (Stratagene) at 95
 
 
 
C for 10 min, followed by 40
cycles at 95
 
 
 
C for 30 s, 58
 
 
 
C for 1 min, and 72
 
 
 
C for 1 min.
Flurometric data were collected at the end of the annealing step in
each cycle, and a dissociation curve was performed at the end of
40 cycles to confirm specificity of amplification. Data were re-
corded using software supplied by the manufacturer and analyzed
using Microsoft Excel. cDNA from the pro–B cell line 38B9 was
used at known relative amounts to construct a seven-point stan-
dard curve for each primer pair in each run. Standard curves for all
primer pairs showed a linear decrease in threshold cycle propor-
tional to the log of relative cDNA input, with correlation coeffi-
cients ranging from 0.9904 to 0.9995. Relative starting cDNA
amounts for unknowns were calculated from the corresponding 
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standard curve and expressed in arbitrary units relative to expres-
sion of the endogenous reference gene HPRT. The primers used
include: E12 sense 5
 
 
 
-GTGGCCGTCATCCTCAGC, E12 anti-
sense 5
 
 
 
-GCTGCTTTGGGGTTCAGG; E47 sense 5
 
 
 
-GCCG-
AAGAGGACAAGAAGG, E47 anti-sense 5
 
 
 
-CTTCTCCTC-
CAGGGACAGC; HEB sense 5
 
 
 
-CGATTAGGAACCCACGA-
AGG, HEB anti-sense 5
 
 
 
-GGAAAATGAGCCTCTCTCTGAT;
and HPRT sense 5
 
 
 
-ACCTCTCGAAGTGTTGGATA, HPRT
anti-sense 5
 
 
 
-CAACAACAAACTTGTCTGGA. RT-PCR was
performed as described previously (9). Control experiments were
performed with RNA isolated from cells lines with known ex-
pression levels of each of the tested genes to confirm the specific-
ity of the real time PCR reactions.
 
Northern Blot Analysis.
 
Isolation of RNA and Northern blot
analysis were performed as described in Kee et al. (22) using
cloned PCR-amplified cDNA fragments from the N-
 
myc
 
, c-
 
myc
 
,
IL-7R
 
 
 
, and actin genes.
 
Electromobility Shift Analysis (EMSA).
 
Whole cell extracts
were prepared by freezing cell pellets at 
 
 
 
70
 
 
 
C for 2–24 h fol-
lowed by lysis in Solution C (20 mM Hepes, pH 7.4, 200 mM
NaCl, 1 mM EDTA, 1 mM EGTA) containing 1% NP-40 and
phosphatase and protease inhibitor cocktails (Sigma-Aldrich).
The lysates were vortexed vigorously for 2 min and incubated for
an additional 15 min with rotation at 4
 
 
 
C. Double stranded DNA
probes were labeled and EMSA was performed exactly as de-
scribed in Kee et al. (17). The sequences of the 
 
 
 
E5 (13), EBF
(27), Pax5 (28), and Oct (29) oligonucleotides have been pub-
lished previously.
 
Results
 
E47
 
 
 
/
 
  
 
FL Cells Fail to Develop into BLPs and Do Not Ex-
press EBF.
 
We examined FL cells from E47
 
 
 
/
 
  
 
and E47
 
 
 
/
 
 
 
embryos at E15.5 for expression of B220, CD19, and c-
 
kit
 
,
markers of early B lineage progenitors. E47
 
 
 
/
 
  
 
mice are
E2A deficient because cells from these mice do not express
detectable levels of E12 or E47 protein (9). Consistent with
previous, studies we found that B220
 
  
 
CD19
 
  
 
and B220
 
 
 
c-
 
kit
 
  
 
cells are absent from E47
 
 
 
/
 
  
 
FL at E15.5, whereas
these cells are present in E47
 
 
 
/
 
  
 
FL (Fig. 1 A). We hypoth-
esized that the absence of B lineage cells in E47
 
 
 
/
 
  
 
FL
might be due to a requirement for E2A to promote EBF
expression. In support of this hypothesis, we found that
E47
 
 
 
/
 
  
 
Lin
 
  
 
FL cells isolated at E14.5 lack EBF mRNA,
whereas EBF was detected in E47
 
 
 
/
 
  
 
or E47
 
 
 
/
 
  
 
Lin
 
  
 
FL
(Fig. 1 B). Similarly, we found that Pax5 mRNA was not
detected in E14.5 E47
 
 
 
/
 
  
 
Lin
 
  
 
FL, consistent with the no-
tion that EBF is required for Pax5 expression.
To study B lymphopoiesis from E47
 
 
 
/
 
  
 
progenitors, we
used an in vitro culture system that supports development
Figure 1. E2A proteins are required for development of
BLPs and expression of EBF and Pax5 in FL. (A) FACS®
analysis for B220 and CD19 (top) or c-kit (bottom)–
expressing cells in the liver E47 /  and E47 /  embryos at
E15.5. (B) Semiquantitative RT-PCR analysis of EBF,
Pax5, and actin mRNA in Lin  cells isolated from E47 / ,
E47 / , or E47 /  FL at E12.5 or E14.5. Threefold serial
dilutions of cDNA, starting at 50 ng/reaction were ampli-
fied for 32 cycles (EBF), 35 cycles (Pax5), or 28 cycles (actin).
In all experiments, RNA that had not been reverse tran-
scribed ( RT) served as a negative control. (C) FACS®
analysis of CD19 expression on E47 / ;GFP (dark line),
E47 / ;GFP (dotted line), and E47 / ;E2A (light line) FL
cells 18 d after infection. (D) RT-PCR analysis of EBF
and actin mRNA from E47 / ;GFP, E47 / ;GFP, and
E47 / ;E2A cells 15 d after infection. 15 ng cDNA was
amplified for 30 cycles (EBF) or 28 cycles (actin). In all
RT-PCR experiments, the lanes being compared were
amplified in parallel and run on the same gel, although the
lanes have been rearranged to aid in comparison.E2A-deficient EBF  Pro–B Lymphocytes 1692
of BLPs from multipotent hematopoietic progenitors (24).
Lin  FL progenitors were isolated from embryos at E12.5
and cultured on a subconfluent layer of irradiated S17 stro-
mal cells in media containing KL and IL-7. At E12.5, EBF
and Pax5 expression are not yet readily detected in Lin 
cells (Fig. 1 B). Under these conditions, E47 /  progeni-
tors give rise to a detectable number of CD19  lymphoid
cells within 7–9 d of culture (Fig. 1 C). By contrast, E47 / 
FL cells fail to give rise to a CD19  lymphoid population
(Fig. 1 C). In fact, E47 /  FL progenitors underwent only
a minor expansion over the first 10–15 d of culture. After
this time, the cells became adherent and resembled macro-
phages, with the majority expressing CD11b. However,
coinfection of E47 /  Lin  FL cells with retroviruses pro-
ducing E12 and E47 was sufficient to rescue the develop-
ment of CD19  cells (Fig. 1 C). E47 /  FL cells infected
with a control retrovirus producing GFP only (E47 / ;
GFP) and E47 /  FL cells expressing E2A (E47 / ;E2A)
both expressed EBF mRNA by RT-PCR (Fig. 1 D).
Analysis of EBF expression in E47 / ;GFP cultures was
complicated by the fact that the stromal cells on which
these progenitors are growing express high levels of EBF.
Because E47 / ;GFP cells fail to undergo extensive ex-
pansion, the recovered cells are highly contaminated with
stromal cells. Regardless, EBF expression was significantly
lower (approximately sixfold) in the E47 / ;GFP cultures
(Fig. 1 D). Therefore, expression of E2A, but not GFP, in
E47 /  Lin  FL progenitors is sufficient to induce the ex-
pression of EBF.
EBF, But Not Pax5, Rescues the Development of B220 
CD19  Cells from E47 /  Progenitors. We tested the hy-
pothesis that EBF is the essential target of E2A leading to B
lymphocyte development by introducing EBF into E47 / 
Lin  FL progenitors and assessing the ability of these cells
to give rise to BLPs in vitro. Remarkably, expression of
EBF was sufficient to promote the development of B220 
CD19  cells from E47 /  progenitors (Fig. 2 A). In addi-
tion, E47 / ;EBF cells underwent significant expansion
resulting in an  80-fold increase in cell numbers by day 18
of culture. By contrast, nonadherent cells in E47 / ;GFP
cultures increased only fourfold during this time (Fig. 2 B).
By day 20 of culture, the majority of cells in E47 / ;GFP
and E47 / ;EBF cultures expressed CD19 and B220 and
 70% also expressed the BLP-associated aminopeptidase
BP-1/6C3 (Fig. 2 C). No CD19  lymphoid cells were de-
tected in cultures of E47 /  progenitors even after 40 d of
continuous culture on S17   KL   IL-7, demonstrating
that there are no rare progenitors present in E47 /  FL ca-
pable of B lineage differentiation under these conditions
(unpublished data). Therefore, EBF is sufficient to pro-
mote the development of CD19  lymphoid cells from
E47 /  FL progenitors.
Figure 2. Development of B220  CD19  BP1 
cells from E47 /  FL progenitors expressing EBF,
but not Pax5. (A) Hematopoietic progenitors were
isolated from E47 /  and E47 /  FL cells at day 12
of gestation, infected with the GFP only, EBF, or
Pax5-producing retrovirus, and cultured on S17
stromal cells in the presence of KL and IL-7. 12 d
after the initiation of culture, the resulting cell pop-
ulations were isolated and stained with antibodies
recognizing CD11b, Gr-1, B220, and CD19. The
plots show B220 and CD19 expression on
CD11b  Gr-1  cells. (B) 18 d after the initiation of
culture, the total number of cells that had devel-
oped from the starting population was determined.
(C) 20 d after the initiation of culture, the indi-
cated cell populations were stained with antibodies
recognizing B220, CD19, or BP-1/6C3.Seet et al. 1693
We also asked whether Pax5, which functions down-
stream of E2A and EBF in the transcriptional hierarchy
leading to B lineage commitment, could rescue the devel-
opment of CD19  cells from E47 /  progenitors. Remark-
ably, infection of E47 /  progenitors with a retrovirus pro-
ducing Pax5 did not lead to significant expansion of these
cells or expression of CD19 (Fig. 2, A and B).
Expression of B Lineage Genes in E47 / ;EBF BLPs. To
determine whether E47 / ;EBF or E47 / ;Pax5 cells ex-
pressed B lineage genes we analyzed total RNA isolated
from these cells by RT-PCR. Surprisingly, most B lineage
genes could be detected in RNA isolated from E47 / ;
EBF cells including those previously shown to be depen-
dent on E2A such as  5 and mb-1 (Fig. 3 A). By contrast,
RT-PCR of RNA isolated from E47 / ;GFP and E47 / ;
Pax5 cells did not reveal expression of any B lineage genes
(Fig. 3 A). To compare the level of B lineage gene expres-
sion in E47 / ;GFP and E47 / ;EBF cells directly, we iso-
lated RNA from sorted CD19  cells and performed a semi-
quantitative RT-PCR (Fig. 3 B). Slight differences in the
level of mRNA were observed for some of these genes be-
tween the two cell types, particularly for the RAG-2 gene.
However these differences are within the range of error of
our RT-PCR reactions (two- to threefold). Therefore, ex-
pression of EBF appears to be sufficient to promote the ex-
pression of most B lineage genes in the absence of E2A.
IgH Chain Rearrangement in E47 / ;EBF BLPs. Next,
we examined the state of rearrangement of the IgH locus, an-
other hallmark of B lineage differentiation that is thought to
be E2A dependent. First, we examined DNA from E47 / ;
GFP and E47 / ;EBF BLPs for the presence of germline IgH
alleles using PCR primers specific for JH4 and intronic DNA
5  of the JH gene segments (Mu0), which is deleted during D
to JH rearrangement (30). We found a similar level of germ-
line IgH loci in the two populations of cells (Fig. 3 C). Subse-
quently, we examined rearrangements of D and JH gene seg-
ments using degenerate primers (DHL and DHR) that detect 9
of the 10 D gene segments and a JH4 primer (30). Using this
assay, rearrangement of D gene segments to all four JH gene
segments could be detected in DNA from E47 / ;GFP BLPs
(Fig. 3 D). Remarkably, a similar pattern of D-JH rearrange-
ments was detected in DNA from E47 / ;EBF BLPs (Fig. 3
D). The level of rearrangement, as judged by the intensity of
each rearranged fragment, also appeared to be similar be-
tween the two populations. Therefore, E47 / ;EBF BLPs are
able to rearrange their IgH D and JH gene segments.
We also examined rearrangements of the V to DJH gene
segments using degenerate PCR primers specific for three
families of V genes: VJ558, V7183, and VQ52 (30). Rearrange-
ments to all three V gene families were observed in DNA
isolated from E47 / ;GFP and E47 / ;EBF BLPs (Fig. 3
E). Therefore, E47 / ;EBF BLPs are capable of V-DJH
rearrangement.
EBF Does Not Induce Expression of HEB or E2-2. We
questioned whether EBF might promote B lymphocyte
development by inducing the expression of alternative
E-box binding proteins. To test this possibility, we measured
HEB and E2-2 mRNA levels in sorted B220  CD19 
E47 / ;GFP and E47 / ;EBF cells by real time RT-PCR.
Both HEB and E2-2 mRNA were increased only 1.3-fold
in E47 / ;EBF compared with E47 / ;GFP cells, indicat-
ing that EBF is not leading to a dramatic increase in HEB
Figure 3. Expression of B lineage genes and IgH
rearrangements in E47 / ;EBF BLPs. (A) RT-PCR
analysis of B lineage gene expression in RNA iso-
lated from E47 / ;GFP, E47 / ;GFP, E47 / ;
EBF, and E47 / ;Pax5 populations 20 d after in-
fection. The input cDNA was standardized such
that a similar amount of actin was amplified under
semiquantitative conditions. In all RT-PCR exper-
iments, the lanes being compared were amplified in
parallel and run on the same gel. The  RT and
 RT lanes were juxtaposed to aid in comparison.
(B) B220  CD19  cells were sorted from cultures
of E47 / ;GFP and E47 / ;EBF cells and total
RNA was extracted. Semiquantitative RT-PCR
was performed on serial threefold dilutions of reverse
transcribed RNA, 50 ng/reaction, using the indi-
cated PCR primers. In all experiments, RNA that
had not been reverse transcribed ( RT) served as
a negative control. (C) PCR-amplified products
from DNA isolated from B220  CD19  E47 / ;
GFP (lane 1) and E47 / ;EBF (lane 2) BLPs using
primers to detect the germline (GL) configuration
of the IgH locus, (D) the JH4 primer in conjunction
with the DHL (L) primer, which detects D-JH rear-
rangements, or the DHR (R) primer, which is in
the opposite orientation and should not amplify D-JH
rearrangements, and (E) the VJ558, V7183, and VQ52
primers in combination with the JH4 primer. All
amplified products were transferred to nylon mem-
brane and probed with a radiolabeled cDNA frag-
ment containing a DJH4 fragment.E2A-deficient EBF  Pro–B Lymphocytes 1694
or E2-2 expression (Fig. 4 A). We also found that EBF did
not restore expression of E12 because E12 mRNA re-
mained 16-fold lower in E47 / ;EBF than in E47 / ;GFP
BLPs (Fig. 4 A). E47 mRNA was not detected in the
E47 / ;EBF cells because these cells contain a targeted de-
letion of the exon encoding the E47 bHLH domain (Fig. 4
A). Therefore, EBF does not promote the development of
B220  CD19  cells from E47 /  progenitors by inducing
the expression of alternative E protein genes.
Expression of EBF and Pax5 with Reduced E-box Binding
Proteins in E47 / ;EBF BLPs. We examined whole cell
extracts from these sorted populations by EMSA and found
a dramatic reduction (approximately eightfold) in E-box
binding proteins in E47 / ;EBF cells compared with the
E47 / ;GFP cells (Fig. 4 B). We also examined these ex-
tracts for EBF and Pax5 protein. Remarkably, both EBF
and Pax5 were present in E47 / ;EBF extracts at levels
comparable to the E47 / ;GFP extracts (Fig. 4 B). Oc-
tamer binding proteins were also present at equivalent lev-
els in both populations, consistent with the presence of
these proteins in all cell types (Fig. 4 B). Therefore, ectopic
expression of EBF in E47 /  hematopoietic progenitors is
sufficient to promote the development of B220  CD19 
cells that have low levels of E-box binding proteins and
levels of EBF and Pax5 that are comparable to E47 / 
BLPs. Moreover, the expression of Pax5 in the E47 / ;
EBF cells indicates that these cells are committed to the B
lymphocyte lineage (31, 32). Consistent with this hypothe-
sis we have not been able to generate macrophages from
CD19  E47 / ;EBF cells in cultures containing S17   KL  
M-CSF (unpublished data).
E47 / ;EBF BLPs Require E Protein Activity for Survival
and Expression of B Lineage Genes. The expression of B
lineage genes in E47 / ;EBF BLPs was surprising because
many of these genes have been shown previously to be tar-
gets of E2A. In addition, E protein activity is required for
the survival of BLPs (22). Therefore, our data indicated
that either: (a) expression of EBF is able to overcome the
need for E proteins in BLPs or (b) that alternative E pro-
teins are expressed at levels sufficient to compensate for the
loss of E2A. The level of expression of HEB and E2-2, and
E-box binding activity, is low in E47 / ;EBF BLPs. How-
ever, it is possible that they are present at sufficient levels to
promote expression of many genes. To determine whether
E protein activity is required for survival or B lineage gene
expression in E47 / ;EBF BLPs, we infected these cells
with a retrovirus that produces an estradiol-inducible E
protein antagonist Id3 (ERId3). As a control, the cells were
infected with a retrovirus producing a mutant form of Id3
(ERId3m). Remarkably, E47 / ;EBF cells were more sen-
sitive to E protein inhibition than E47 / ;GFP cells as
demonstrated by the increased proportion of cells staining
with annexin V 9 h after induction of ERId3 (Fig. 5 A). In
a similar experiment, E47 / ;GFP and E47 / ;EBF BLPs
were infected with an Id3-producing virus (in this case co-
expressing the extracellular domain of human CD25 in-
stead of GFP) or hCD25-producing virus and hCD25 
cells were isolated by flow cytometry 20 h after infection.
RT-PCR analysis of RNA isolated from these cells re-
vealed that Id3 caused a decrease in expression of RAG-1
and RAG-2, but not CD19, mRNA in E47 / ;EBF cells
(Fig. 5 B). Therefore, the low level of HEB and E2-2
present in E47 / ;EBF cells is required for the survival of
BLPs and expression of the RAG genes.
E47 / ;EBF BLPs Have Reduced Responsiveness to IL-7.
Our data demonstrate that EBF is the major target of E2A re-
quired for B lineage specification. However, one apparent
difference between cultures of E47 / ;GFP and E47 / ;EBF
BLPs was the rate at which cell numbers increased over time.
Although a significant number of E47 / ;EBF BLPs were
generated by days 12–15 of culture, the subsequent expansion
Figure 4. EBF does not induce E protein mRNA or protein in
E47 / ;EBF cells. (A) Total RNA isolated from sorted B220  CD19 
E47 / ;GFP (open bars) and E47 / ;EBF (solid bars) cells at day 20 of
culture was analyzed by real time PCR for expression of E12, E47, HEB,
and E2-2. The abundance of target mRNA relative to the level of HPRT
mRNA is shown. Error bars represent the standard error of five replicate
samples. (B) EMSA of whole cell protein extracts prepared from sorted
B220  CD19  E47 / ;GFP (lanes 1 and 2) and E47 / ;EBF (lanes 3 and
4) cells 25 d after the initiation of culture. The extracts were incubated
with the probe in the presence of a noncompetitive (lanes 1 and 3) or
competitive (lanes 2 and 4) oligonucleotide, except in the case of the Oct
probe, where no competitive oligonucleotide was added. Lanes 1–4 for
each of the probes were run on the same gel. The probes used include the
E-box–containing  E5 probe, the EBF site from the mb-1 promoter, a
composite Pax5/ets site from the mb-1 promoter, and an Octamer protein
binding sequence as indicated at the bottom of the panel.Seet et al. 1695
of these cells was much slower than E47 / ;GFP BLPs. To
determine why there were fewer cells in cultures of E47 / ;
EBF BLPs, we examined their cloning efficiency compared
with E47 / ;GFP cells under limiting dilution conditions in
the presence of S17   KL   IL-7 or IL-7 alone. In three in-
dependent experiments, we found that the frequency of puri-
fied B220  CD19  cells that could proliferate in response to
IL-7 in the presence of S17   KL was similar (within two-
fold) between E47 / ;GFP and E47 / ;EBF CD19  cells,
although the colony size was consistently smaller in the latter
cultures (Table I). Remarkably, the frequency of E47 / ;
EBF BLPs that could respond to IL-7 alone was dramatically
lower (between 5- and 10-fold) than E47 / ;GFP cells with
only a few rare progenitors proliferating enough to score as a
positive response (Table I). After 4 d, no viable cells remained
in E47 / ;EBF IL-7, only cultures. Therefore, E47 / ;EBF
BLPs do not respond appropriately to IL-7.
To examine further the ability of E47 / ;EBF BLPs to
respond to IL-7, we plated the cells in bulk culture and al-
lowed them to expand for 48 h before determining viable
cell numbers. In the presence of S17   KL   IL-7, there
was a 10-fold expansion of E47 / ;GFP BLPs (Fig. 6 A).
By contrast, there was only a 1.9-fold expansion of E47 / ;
EBF BLPs under the same conditions (Fig. 6 A, p   0.02).
In the presence of IL-7 alone, E47 / ;GFP cells expanded
6.2-fold, whereas E47 / ;EBF BLPs decreased in number
by  1.9-fold (Fig. 6 A, p   0.004). Therefore, under either
culture condition there was a dramatically impaired ability
of the E47 / ;EBF BLPs to expand in response to IL-7.
Both BLP populations were dependent on IL-7 because re-
moval of IL-7 from the culture media resulted in a decrease
in cell numbers and significant apoptosis (unpublished data).
To determine whether the decreased expansion of E47 / ;
EBF BLPs in S17   KL   IL-7 was due to reduced pro-
liferation, we examined the cell cycle status of progenitors
using BrdU and PI. During a 20-min incubation with
BrdU, E47 / ;EBF BLPs had  30% more cells in the G1
phase of the cell cycle (BrdU , 2N DNA content) com-
pared with E47 / ;GFP cells (59.5 vs. 44.5%; Fig. 6 B).
Moreover,  30% fewer cells were in the S phase (BrdU )
in cultures of E47 / ;EBF BLPs (Fig. 6 B). From these data
we conclude that E47 / ;EBF BLPs proliferate less well in
response to IL-7 than E47 / ;GFP BLPs.
Decreased Expression of N-myc in E47 / ;EBF BLPs.
We considered the possibility that a decrease in E protein
activity might affect the expression of the IL-7R on BLPs
as IL-7-R  has previously been suggested to be an E2A-
dependent gene (17). However, by Northern blot analysis
we found that IL-7R  mRNA was expressed at equivalent
levels in the two populations of cells (Fig. 6 C). In addition,
IL-7R  could be detected on the surface of these cells by
flow cytometry (unpublished data). Therefore, the poor
proliferative response of E47 / ;EBF BLPs to IL-7 is un-
likely to be due to the absence of IL-7R expression.
To gain a better understanding of the alterations in
E47 / ;EBF BLPs that lead to this proliferation defect, we
analyzed gene expression patterns in two populations of
paired E47 / ;GFP and E47 / ;EBF BLPs using Affy-
metrix 430A microarrays. Surprisingly, we found few genes
that were consistently reduced by more than twofold in
E47 / ;EBF cells compared with E47 / ;GFP cells (in-
cluding the B lineage genes present on the chip, although
Figure 5. E47 / ;EBF BLPs require E protein
activity for survival and expression of RAG-1 and
RAG-2. (A) E47 / ;GFP and E47 / ;EBF BLPs
were infected with ERId3m (solid bars) or ERId3
(gray bars). 24 h after infection, the cells were
treated with 1  M estradiol for 9 h and the percent
of GFPhi cells binding annexin V was determined
by flow cytometry. (B) E47 / ;GFP and E47 / ;
EBF BLPs were infected with hCD25- or Id3/
hCD25-producing retrovirus. 24 h after infection,
hCD25  cells were isolated and total RNA was ex-
tracted and reverse transcribed for analysis by semi-
quantitative RT-PCR. Expression of RAG-1,
RAG-2, CD19, and actin are shown. In all RT-PCR
experiments, the lanes being compared were ampli-
fied in parallel and run on the same gel. The  RT
and  RT lanes were juxtaposed after photograph-
ing the gel.
Table I. Frequency of CD19  Cells Responsive to S17   KL   
IL-7 or IL-7 Alone
Culture conditions
Experiment Sample S17   KL   IL-7 IL-7
1 E47   ;GFP 1:17 1:43
E47   ;EBF 1:30 1:280
2 E47   ;GFP  1:10a 1:21
E47   ;EBF  1:10a 1:204
3 E47   ;GFP 1:20 ND
E47   ;EBF 1:35 ND
The frequency was determined as the average number of cells per well,
where 37% of wells were nonresponding. For each determination, three
cell concentrations were plated with a minimum of 48 wells each.
aAll wells were positive when plated at 10 cells/well.E2A-deficient EBF  Pro–B Lymphocytes 1696
RAG-2 was consistently reduced by twofold). The most
notable difference was in expression of N-myc, a transcrip-
tion factor involved in cell proliferation and a known target
of IL-7R signaling in BLPs (33). By Northern blot analysis
we found that N-myc mRNA was consistently decreased
by approximately threefold (range 2.8–3.1) in E47 / ;EBF
cells cultured in S17   KL   IL-7 (Fig. 6 C). We detected
only a marginal (less than twofold) reduction in c-myc
mRNA in E47 / ;EBF BLPs (Fig. 6 C). However, the re-
duced expression of N-myc in E47 / ;EBF BLPs could be
sufficient to cause the decreased proliferation observed in
these cells in response to IL-7.
E Protein Activity Is Required for Expression of N-myc in
BLPs. Our previous data demonstrated that E proteins are
required for the proliferation of BLPs because ectopic ex-
pression of Id3 induces cell cycle arrest in these cells (22). To
determine whether N-myc expression in BLPs requires E
protein activity, we infected FL BLPs with the ERId3 or
ERId3m retrovirus to antagonize E protein activity. ERId3-
and ERId3m-expressing cells were isolated by sorting for
GFP  cells and were allowed to recover in culture before the
addition of 1  M 17 -estradiol for 6 h and extraction of
RNA. By Northern blot analysis we found that expression
of ERId3, but not ERId3m, led to a decline in expression of
both N-myc and c-myc mRNA (2.6- and 4.7-fold, respec-
tively; Fig. 6 D). Therefore, optimal N-myc and c-myc ex-
pression in BLPs is E protein dependent. Interestingly, the
level of E protein activity in E47 / ;EBF BLPs appears to be
sufficient to allow expression of c-myc, but not optimal ex-
pression of N-myc. Taken together, our data suggest that the
reduced proliferative response of E47 / ;EBF BLPs to IL-7
might be due to the inability of these cells to fully activate
N-myc expression in the absence of E2A proteins.
N-myc Promotes Proliferation of E47 / ;EBF BLPs. To
test the hypothesis that decreased expression of N-myc is
responsible for the observed defect in IL-7 responsiveness
in E47 / ;EBF BLPs, we introduced N-myc into these
cells and examined their ability to respond to IL-7. Previ-
ous studies have demonstrated that high levels of N-myc
lead to cell death (34). Consistent with this, we found that
a significant percentage of E47 / ;GFP and E47 / ;EBF
BLPs infected with the N-myc retrovirus underwent apop-
tosis within the first 48 h after infection. However, after
this time there was an increase in cells with intermediate
levels of GFP that were viable and presumably expressing
levels of N-myc that do not induce apoptosis. Therefore,
we used this population of cells to quantify the expansion
of N-myc or GFP virus–infected cells in the presence of
S17   KL   IL-7 or IL-7 alone (Fig. 7 A). After 48 h of
culture, there was an approximate sixfold increase in E47 / ;
GFP cells in S17    KL     IL-7 cultures regardless of
whether the cells were infected with GFP or N-myc virus.
In contrast, only a twofold increase in cell numbers was
observed in S17   KL   IL-7 cultures of E47 / ;EBF
BLPs infected with GFP virus (Fig. 7 A). However, E47 / ;
EBF BLPs infected with N-myc–producing virus under-
went a greater expansion resulting in a threefold increase in
cell numbers (P   0.03). Similarly, in the presence of IL-7
alone, N-myc did not affect the number of cells recovered
from E47 / ;GFP cultures, whereas it resulted in a fivefold
increase in cell numbers from E47 / ;EBF BLPs compared
with GFP virus–infected cells (Fig. 7 B; P   0.001). The
rescue of BLP numbers in E47 / ;EBF IL-7 cultures was
particularly evident upon visual examination because BLPs
infected with GFP virus had essentially no viable cells,
whereas numerous small colonies could be detected in the
N-myc–infected cultures. Moreover, we have been able to
establish long-term ( 2 mo) cultures of E47 / ;EBF cells
expressing N-myc in IL-7, whereas the same cells lacking
N-myc fail to survive (unpublished data). These data dem-
onstrate that ectopic expression of N-myc is sufficient to
promote the survival or expansion of E47 / ;EBF cells.
However, this rescue appears to be critically dependent on
the dose of N-myc.
To confirm further our observation that N-myc pro-
motes proliferation of E47 / ;EBF cells, we used BrdU in-
Figure 6. E47 / ;EBF BLPs proliferate less well than E47 / ;GFP BLPs and have reduced expression of N-myc. (A) 105 B220  CD19  cells from
E47 / ;GFP (solid bars) and E47 / ;EBF (gray bars) cultures were plated in IL-7 alone or S17   KL   IL-7. 48 h later, the cells were harvested and
counted on the hemacytometer. The standard error of three replicate cultures is indicated. The p-values were generated using a Student’s t test. (B) Cell
cycle analysis using BrdU and PI of E47 / ;GFP and E47 / ;EBF BLPs cultured on S17   KL   IL-7. The percentage of cells in each phase of the cell
cycle is plotted. The data represent one of two independent experiments. (C) Northern blot analysis of RNA extracted from E47 / ;GFP and E47 / ;EBF
BLPs or (D) BLPs expressing ERId3 or ERId3m after treatment with 1  M 17 -estradiol for 6 h. The probes used are indicated on the right of each panel.Seet et al. 1697
corporation and PI staining to determine the percent of
cells in each phase of the cell cycle. This analysis revealed
that N-myc promoted an increase in the percent of E47 / ;
EBF cells in S phase when cultured on S17   KL   IL-7
or IL-7 alone as compared with GFP virus–infected cells
(32.9 vs. 27% and 21 vs. 14.7%, respectively; Fig. 7, C and
D). In contrast, an increase in the percent of BLPs in S
phase was observed for E47 / ;GFP   N-myc cells in IL-7
cultures only (40.6 vs. 39.6% in S17   KL   IL-7 and 45.7
vs. 35.8% in IL-7 alone). It is currently unclear why this in-
crease in S phase E47 / ;GFP   N-myc cells did not trans-
late into an increase in cell numbers as was observed for the
E47 / ;EBF   N-myc cells. One possibility is that the in-
crease in cell cycle was balanced by an increase in cell death
as this population of cells had a more heterogeneous ex-
pression of the N-myc retrovirus compared with E47 / ;
EBF cells (unpublished data). Taken together, our data
demonstrate the N-myc can promote the ability of E47 / ;
EBF cells to survive and proliferate in the presence of IL-7.
Discussion
We have demonstrated that the block in B lymphocyte
development imposed by the absence of E2A proteins can
be overcome by ectopic expression of the E2A target gene
EBF. Expression of EBF in E2A-deficient FL progenitors is
sufficient to promote the development of B220  CD19 
BP1/6C3  cells that express most B lineage genes and un-
dergo VDJ recombination at the IgH locus. The ability of
EBF to rescue the development of BLPs from progenitors
that lack E2A proteins afforded us the opportunity to ex-
amine these cells for additional defects that might be attrib-
uted to the reduced level of E proteins. This analysis re-
vealed that E2A proteins are also required for optimal
expression of N-myc, a target of IL-7 signaling in BLPs that
is associated with proliferation (33). In agreement with this
finding, E47 / ;EBF BLPs had minimal cloning efficiency
in IL-7 alone and did not proliferate optimally in response
to IL-7 even in the presence of stromal cells and KL.
Moreover, this defective response to IL-7 could be restored
partially by ectopic expression of N-myc in E47 / ;EBF
BLPs. Therefore, the major function of E2A proteins in B
lymphocyte lineage specification is to induce EBF as well as
maintain an appropriate context for responsiveness to the
cytokine IL-7. Our data also demonstrate that a higher
threshold of E protein activity is required for activation of
EBF and N-myc as compared with other B lineage genes.
A recent study suggested that activation of EBF might
be the limiting factor driving B lymphocyte development
from common lymphoid progenitors (35). However, the
ability of BLPs to develop in the absence of E2A was unex-
pected because E2A is thought to play an essential role in
promoting expression of B lineage–associated genes in co-
operation with other B lineage transcription factors includ-
ing EBF (2, 3, 19, 20, 36). Our data indicate that the low
level of alternative E proteins in these cells is sufficient to
function in a combinatorial manner with other transcrip-
tion factors to promote lymphocyte survival and expression
Figure 7. N-myc promotes the proliferation of
E47 / ;EBF BLPs. (A) E47 / ;GFP and E47 / ;
EBF BLPs were infected with GFP (solid bars) or
N-myc (gray bars)–producing retrovirus and 48 h
later, three replicate wells of 105 cells were plated
on S17   KL   IL-7 (right) or IL-7 alone (left).
The total number of cells present in each well was
determined 48 h later. The p-values were gener-
ated using a Student’s t test. (B) 96 h after infection
with GFP or N-myc retrovirus, E47 / ;GFP and
E47 / ;EBF BLPs were incubated for 20 min with
BrdU and then stained with anti-BrdU and PI. The
percent of cells in each phase of the cell cycle was
determined by flow cytometry.E2A-deficient EBF  Pro–B Lymphocytes 1698
of most B lineage genes. This finding is consistent with the
hypothesis that E proteins are largely redundant in func-
tion and that E2A proteins specifically are required for B
lymphocyte development because E47 is present at much
higher levels than other E proteins in BLPs. It is also evi-
dent that higher levels of E protein activity are required for
the initial induction of EBF than for expression of most
other B lineage genes. Whether this requirement is due to
the affinity of E proteins for the relevant E-box sites in the
EBF regulatory elements, or due to the mechanism of acti-
vation of the EBF gene, such as a need for high E-box oc-
cupancy for acetylation of chromatin, remains to be deter-
mined. Interestingly, the reported EBF promoter contains
one high affinity E-box site upstream of two potential
Ikaros binding sites, which could function to keep the EBF
locus in a repressed chromatin conformation (18, 37). A
high level of E protein expression might be required to
maintain occupancy of the E-box site in repressed chroma-
tin to ensure activation. Alternatively, there might be addi-
tional E-box sites in an EBF enhancer that require high
levels to E proteins for maximal binding. In contrast, the
mb-1 promoter, which is activated in E47 / ;EBF BLPs
that have low levels of E protein activity, has binding sites
for multiple B lineage transcription factors including EBF,
E2A (or E proteins), Oct, and Pax5 (20). Cooperative
binding of these factors to the mb-1 promoter may reduce
the concentration of E protein required to achieve stable
promoter activation. Further studies will be required to de-
termine the mechanism of E protein function in the regula-
tion of the EBF and mb-1 genes.
A recent study by Ikawa et al. (38) identified rare pro-
genitors in the Lin  fraction of E12 /  BM that were able
to form stable cell lines in vitro. These E12 /  lines ex-
pressed a number of B lineage genes at low levels but re-
mained capable of multilineage hematopoietic reconstitu-
tion after transfer into lethally irradiated mice. In contrast
to this study, we did not find evidence of in vitro expan-
sion of cells expressing B lineage genes from the Lin  frac-
tion of E47 /  FL. We were only able to detect cells ex-
pressing B lineage genes after expression of EBF, and not
Pax5, in E47 /  FL cells. Moreover, expression of EBF in
E47 /  FL is sufficient to promote B lineage commitment
because the cells began to express CD19 and Pax5 and
were unable to differentiate into myeloid cells in the pres-
ence of M-CSF. The observed differences between the
Ikawa study and ours might be the results of the origin of
the progenitors (FL vs. BM), the culture conditions used,
or the genotype of the mice (E47 /  vs. E12 / ). How-
ever, our results clearly indicate that EBF is the essential
target of E2A proteins required for B lymphopoiesis.
Our previous studies demonstrated that inhibition of E
protein activity in BLPs by ectopic expression of Id3 in-
duces growth arrest and apoptosis (22). Interestingly, the
low level of E protein activity remaining in E47 / ;EBF
BLPs is sufficient to sustain the viability of these cells in the
absence of E2A. However, E47 / ;EBF BLPs are exquis-
itely sensitive to the expression of Id3, further confirming
the need for HEB and/or E2-2 to promote B lymphopoie-
sis in the absence of E2A. Regardless, HEB and E2-2 are
not sufficient to promote all aspects of B lymphopoiesis
in E47 / ;EBF cells as these cells have reduced N-myc
mRNA levels and do not proliferate well in response to IL-7.
IL-7 has been shown to maintain both N-myc and c-myc
expression in BLPs, and the overall level of myc proteins is
a major factor driving expansion of these cells (33, 39). Re-
markably, we were able to increase the response of E47 / ;
EBF cells to IL-7 by ectopic expression of N-myc, although
this response appears to be critically dependent on the level
of N-myc expression. Our findings indicate that the re-
duced expression of N-myc is likely to be the cause of the
poor proliferative response of E47 / ;EBF BLPs to IL-7.
Interestingly, we found that optimal expression of both
N-myc and c-myc depends on E protein activity in BLPs
because both were reduced in cells expressing ERId3. This
observation indicates that the low level of N-myc in E47 / ;
EBF cells might be the direct consequence of the absence
of E2A and not a consequence of growth arrest, which
would also cause a decline in c-myc expression. The reason
that c-myc expression was less affected in E47 / ;EBF BLPs
is not clear, but suggests that distinct thresholds of E pro-
tein activity are required for optimal expression of c-myc
and N-myc mRNA. Our observations place N-myc into a
unique class of B lineage genes, including EBF, which re-
quire high levels of E protein activity for their maximal ex-
pression. Our data do not, however, require that N-myc be
a direct transcriptional target of E proteins. The possibility
remains that E proteins regulate the expression of a distinct
gene that is required for the induction of N-myc in re-
sponse to IL-7.
IL-7R signals have also been implicated in the regulation
of V gene usage at the IgH locus (40, 41). In the absence of
IL-7R , V gene segments of the VJ558 family are rearranged
less efficiently than V7183 family members. We found that
E47 / ;EBF BLPs had a slight alteration in V gene usage.
The VJ558 family of V gene segments was used with slightly
less efficiency than V7183 and VQ52 gene segments (Fig. 3 D).
It is possible that the decreased rearrangement of VJ558
is due to reduced IL-7R–mediated activation of N-myc
in E47 / ;EBF BLPs. However, an alternative and more
likely possibility is that E protein activity has a stronger in-
fluence on the activation of promoters upstream of VJ558
gene segments than V7183 or VQ52 gene segments. The hy-
pothesis that E proteins may influence expression of a sub-
set of V gene segments is consistent with the differential us-
age of V  and V  gene segments reported in nonlymphoid
cells transfected with E2A or EBF (42).
The IL-7R signaling pathway has also been implicated in
the induction of the Pax5 gene (40). E47 / ;EBF BLPs ex-
press Pax5 at levels comparable to E47 / ;GFP cells, indi-
cating that the IL-7R signaling pathway leading to the in-
duction of Pax5 is not affected by the absence of E2A.
Alternatively, ectopic expression of EBF might be able to
induce Pax5 expression even in the absence of the IL-7–
derived signal. EBF can bind to a sequence in the region 5 Seet et al. 1699
of the Pax5 gene and induces expression of Pax5 in the
70Z/3 macrophage cell line, suggesting that Pax5 might be
a direct target of EBF (17, 21). Interestingly, the 70Z/3
macrophage cell line has no detectable E-box binding pro-
teins, indicating that the induction of Pax5 in these cells
may not require E proteins directly (17). Therefore, EBF
might be the major B lineage transcription factor driving
expression of Pax5. Taken together, our data demonstrate
that E2A proteins play an essential function in coordinating
both the differentiation and expansion of B lineage progen-
itors by induction of EBF and N-myc.
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